Risk of Arterial Ischemic Events After Intracerebral Hemorrhage

BACKGROUND AND PURPOSE—The risk of arterial ischemic events after intracerebral hemorrhage (ICH) is poorly understood given the lack of a control group in prior studies. This study aimed to evaluate the risk of acute ischemic stroke and myocardial infarction (MI) among patients with and without ICH....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stroke (1970) 2020-01, Vol.51 (1), p.137-142
Hauptverfasser: Murthy, Santosh B., Diaz, Ivan, Wu, Xian, Merkler, Alexander E., Iadecola, Costantino, Safford, Monika M., Sheth, Kevin N., Navi, Babak B., Kamel, Hooman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 142
container_issue 1
container_start_page 137
container_title Stroke (1970)
container_volume 51
creator Murthy, Santosh B.
Diaz, Ivan
Wu, Xian
Merkler, Alexander E.
Iadecola, Costantino
Safford, Monika M.
Sheth, Kevin N.
Navi, Babak B.
Kamel, Hooman
description BACKGROUND AND PURPOSE—The risk of arterial ischemic events after intracerebral hemorrhage (ICH) is poorly understood given the lack of a control group in prior studies. This study aimed to evaluate the risk of acute ischemic stroke and myocardial infarction (MI) among patients with and without ICH. METHODS—We performed a retrospective cohort study using claims data from Medicare beneficiaries from 2008 to 2014. Our exposure was acute ICH, identified using validated International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Our primary outcome was a composite of acute ischemic stroke and MI, whereas secondary outcomes were ischemic stroke alone and MI alone. We used Cox regression analysis to compute hazard ratios during 1-month intervals after ICH. Sensitivity analyses entailed exclusion of patients with atrial fibrillation and valvular heart disease. RESULTS—Among 1 760 439 Medicare beneficiaries, 5924 had ICH. The 1-year cumulative incidence of an arterial ischemic event was 5.7% (95% CI, 4.8–6.8) in patients with ICH and 1.8% (95% CI, 1.7–1.9) in patients without ICH. After adjusting for potential confounders, the risk of an arterial ischemic event remained significantly increased for the first 6 months after ICH and was especially high in the first month (hazard ratio, 6.7 [95% CI, 5.0–8.6]). In secondary analysis, the risk of ischemic stroke was increased in the first 6 months after ICH (hazard ratio, 6.1 [95% CI, 3.5–9.3]) but the risk of MI was not (hazard ratio, 1.6 [95% CI, 0.3–2.9]). In sensitivity analyses excluding patients with atrial fibrillation and valvular heart disease, the association between ICH and arterial ischemic events was similar to that of the primary analysis. CONCLUSIONS—In a large population-based cohort, we found that elderly patients with ICH had a substantially increased risk of ischemic stroke in the first 6 months after diagnosis. Further exploration of this risk is needed to determine optimal secondary prevention strategies for these patients.
doi_str_mv 10.1161/STROKEAHA.119.026207
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7001742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2319195205</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5687-4dffee53e2b9801efd168472a02b8c5636f5903d4e44452e3de47963f71247463</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhi0Egu3Sf1BVOXIJjL_jS1GEtt0VSEh8nC1vMiYpyQbsLKj_vqa7XbUXOFmv5pnXM-8Q8oXCKaWKnt3e3Vxfzsp5maQ5BaYY6D0yoZKJXChW7JMJADc5E8YckU8x_gQAxgt5SI441ZoKWUzI-U0bH7PBZ2UYMbSuyxaxarBvq2z2gqsxZqVPhWyxGoOrMOAyJGaO_RBC4x7wmBx410X8vH2n5P777O5inl9d_1hclFd5JVWhc1F7jyg5sqUpgKKvqSqEZg7YskgIV14a4LVAIYRkyGsU2ijuNWVCC8Wn5NvG92m97LGu8G2ezj6Ftnfhlx1ca_-vrNrGPgwvVgNQLVgyONkahOF5jXG0fRsr7Dq3wmEdLePUUCMZyISKDVqFIcaAfvcNBfuWvd1ln6Sxm-xT29d_R9w1_Q07AcUGeB26lGl87NavGGyDrhubj7zFO63psKCVhpwBS-smlf-5Nf8NRIehlw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2319195205</pqid></control><display><type>article</type><title>Risk of Arterial Ischemic Events After Intracerebral Hemorrhage</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Murthy, Santosh B. ; Diaz, Ivan ; Wu, Xian ; Merkler, Alexander E. ; Iadecola, Costantino ; Safford, Monika M. ; Sheth, Kevin N. ; Navi, Babak B. ; Kamel, Hooman</creator><creatorcontrib>Murthy, Santosh B. ; Diaz, Ivan ; Wu, Xian ; Merkler, Alexander E. ; Iadecola, Costantino ; Safford, Monika M. ; Sheth, Kevin N. ; Navi, Babak B. ; Kamel, Hooman</creatorcontrib><description>BACKGROUND AND PURPOSE—The risk of arterial ischemic events after intracerebral hemorrhage (ICH) is poorly understood given the lack of a control group in prior studies. This study aimed to evaluate the risk of acute ischemic stroke and myocardial infarction (MI) among patients with and without ICH. METHODS—We performed a retrospective cohort study using claims data from Medicare beneficiaries from 2008 to 2014. Our exposure was acute ICH, identified using validated International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Our primary outcome was a composite of acute ischemic stroke and MI, whereas secondary outcomes were ischemic stroke alone and MI alone. We used Cox regression analysis to compute hazard ratios during 1-month intervals after ICH. Sensitivity analyses entailed exclusion of patients with atrial fibrillation and valvular heart disease. RESULTS—Among 1 760 439 Medicare beneficiaries, 5924 had ICH. The 1-year cumulative incidence of an arterial ischemic event was 5.7% (95% CI, 4.8–6.8) in patients with ICH and 1.8% (95% CI, 1.7–1.9) in patients without ICH. After adjusting for potential confounders, the risk of an arterial ischemic event remained significantly increased for the first 6 months after ICH and was especially high in the first month (hazard ratio, 6.7 [95% CI, 5.0–8.6]). In secondary analysis, the risk of ischemic stroke was increased in the first 6 months after ICH (hazard ratio, 6.1 [95% CI, 3.5–9.3]) but the risk of MI was not (hazard ratio, 1.6 [95% CI, 0.3–2.9]). In sensitivity analyses excluding patients with atrial fibrillation and valvular heart disease, the association between ICH and arterial ischemic events was similar to that of the primary analysis. CONCLUSIONS—In a large population-based cohort, we found that elderly patients with ICH had a substantially increased risk of ischemic stroke in the first 6 months after diagnosis. Further exploration of this risk is needed to determine optimal secondary prevention strategies for these patients.</description><identifier>ISSN: 0039-2499</identifier><identifier>EISSN: 1524-4628</identifier><identifier>DOI: 10.1161/STROKEAHA.119.026207</identifier><identifier>PMID: 31771458</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Aged ; Aged, 80 and over ; Anticoagulants - therapeutic use ; Atrial Fibrillation - complications ; Atrial Fibrillation - epidemiology ; Brain Ischemia - drug therapy ; Brain Ischemia - epidemiology ; Cerebral Hemorrhage - drug therapy ; Cerebral Hemorrhage - epidemiology ; Female ; Humans ; Male ; Myocardial Infarction - drug therapy ; Myocardial Infarction - epidemiology ; Stroke - drug therapy ; Stroke - epidemiology ; United States ; Warfarin - therapeutic use</subject><ispartof>Stroke (1970), 2020-01, Vol.51 (1), p.137-142</ispartof><rights>American Heart Association, Inc.</rights><rights>2020 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5687-4dffee53e2b9801efd168472a02b8c5636f5903d4e44452e3de47963f71247463</citedby><cites>FETCH-LOGICAL-c5687-4dffee53e2b9801efd168472a02b8c5636f5903d4e44452e3de47963f71247463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3687,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31771458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murthy, Santosh B.</creatorcontrib><creatorcontrib>Diaz, Ivan</creatorcontrib><creatorcontrib>Wu, Xian</creatorcontrib><creatorcontrib>Merkler, Alexander E.</creatorcontrib><creatorcontrib>Iadecola, Costantino</creatorcontrib><creatorcontrib>Safford, Monika M.</creatorcontrib><creatorcontrib>Sheth, Kevin N.</creatorcontrib><creatorcontrib>Navi, Babak B.</creatorcontrib><creatorcontrib>Kamel, Hooman</creatorcontrib><title>Risk of Arterial Ischemic Events After Intracerebral Hemorrhage</title><title>Stroke (1970)</title><addtitle>Stroke</addtitle><description>BACKGROUND AND PURPOSE—The risk of arterial ischemic events after intracerebral hemorrhage (ICH) is poorly understood given the lack of a control group in prior studies. This study aimed to evaluate the risk of acute ischemic stroke and myocardial infarction (MI) among patients with and without ICH. METHODS—We performed a retrospective cohort study using claims data from Medicare beneficiaries from 2008 to 2014. Our exposure was acute ICH, identified using validated International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Our primary outcome was a composite of acute ischemic stroke and MI, whereas secondary outcomes were ischemic stroke alone and MI alone. We used Cox regression analysis to compute hazard ratios during 1-month intervals after ICH. Sensitivity analyses entailed exclusion of patients with atrial fibrillation and valvular heart disease. RESULTS—Among 1 760 439 Medicare beneficiaries, 5924 had ICH. The 1-year cumulative incidence of an arterial ischemic event was 5.7% (95% CI, 4.8–6.8) in patients with ICH and 1.8% (95% CI, 1.7–1.9) in patients without ICH. After adjusting for potential confounders, the risk of an arterial ischemic event remained significantly increased for the first 6 months after ICH and was especially high in the first month (hazard ratio, 6.7 [95% CI, 5.0–8.6]). In secondary analysis, the risk of ischemic stroke was increased in the first 6 months after ICH (hazard ratio, 6.1 [95% CI, 3.5–9.3]) but the risk of MI was not (hazard ratio, 1.6 [95% CI, 0.3–2.9]). In sensitivity analyses excluding patients with atrial fibrillation and valvular heart disease, the association between ICH and arterial ischemic events was similar to that of the primary analysis. CONCLUSIONS—In a large population-based cohort, we found that elderly patients with ICH had a substantially increased risk of ischemic stroke in the first 6 months after diagnosis. Further exploration of this risk is needed to determine optimal secondary prevention strategies for these patients.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anticoagulants - therapeutic use</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Brain Ischemia - drug therapy</subject><subject>Brain Ischemia - epidemiology</subject><subject>Cerebral Hemorrhage - drug therapy</subject><subject>Cerebral Hemorrhage - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Stroke - drug therapy</subject><subject>Stroke - epidemiology</subject><subject>United States</subject><subject>Warfarin - therapeutic use</subject><issn>0039-2499</issn><issn>1524-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1P3DAQhi0Egu3Sf1BVOXIJjL_jS1GEtt0VSEh8nC1vMiYpyQbsLKj_vqa7XbUXOFmv5pnXM-8Q8oXCKaWKnt3e3Vxfzsp5maQ5BaYY6D0yoZKJXChW7JMJADc5E8YckU8x_gQAxgt5SI441ZoKWUzI-U0bH7PBZ2UYMbSuyxaxarBvq2z2gqsxZqVPhWyxGoOrMOAyJGaO_RBC4x7wmBx410X8vH2n5P777O5inl9d_1hclFd5JVWhc1F7jyg5sqUpgKKvqSqEZg7YskgIV14a4LVAIYRkyGsU2ijuNWVCC8Wn5NvG92m97LGu8G2ezj6Ftnfhlx1ca_-vrNrGPgwvVgNQLVgyONkahOF5jXG0fRsr7Dq3wmEdLePUUCMZyISKDVqFIcaAfvcNBfuWvd1ln6Sxm-xT29d_R9w1_Q07AcUGeB26lGl87NavGGyDrhubj7zFO63psKCVhpwBS-smlf-5Nf8NRIehlw</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Murthy, Santosh B.</creator><creator>Diaz, Ivan</creator><creator>Wu, Xian</creator><creator>Merkler, Alexander E.</creator><creator>Iadecola, Costantino</creator><creator>Safford, Monika M.</creator><creator>Sheth, Kevin N.</creator><creator>Navi, Babak B.</creator><creator>Kamel, Hooman</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202001</creationdate><title>Risk of Arterial Ischemic Events After Intracerebral Hemorrhage</title><author>Murthy, Santosh B. ; Diaz, Ivan ; Wu, Xian ; Merkler, Alexander E. ; Iadecola, Costantino ; Safford, Monika M. ; Sheth, Kevin N. ; Navi, Babak B. ; Kamel, Hooman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5687-4dffee53e2b9801efd168472a02b8c5636f5903d4e44452e3de47963f71247463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anticoagulants - therapeutic use</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Brain Ischemia - drug therapy</topic><topic>Brain Ischemia - epidemiology</topic><topic>Cerebral Hemorrhage - drug therapy</topic><topic>Cerebral Hemorrhage - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Stroke - drug therapy</topic><topic>Stroke - epidemiology</topic><topic>United States</topic><topic>Warfarin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murthy, Santosh B.</creatorcontrib><creatorcontrib>Diaz, Ivan</creatorcontrib><creatorcontrib>Wu, Xian</creatorcontrib><creatorcontrib>Merkler, Alexander E.</creatorcontrib><creatorcontrib>Iadecola, Costantino</creatorcontrib><creatorcontrib>Safford, Monika M.</creatorcontrib><creatorcontrib>Sheth, Kevin N.</creatorcontrib><creatorcontrib>Navi, Babak B.</creatorcontrib><creatorcontrib>Kamel, Hooman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Stroke (1970)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murthy, Santosh B.</au><au>Diaz, Ivan</au><au>Wu, Xian</au><au>Merkler, Alexander E.</au><au>Iadecola, Costantino</au><au>Safford, Monika M.</au><au>Sheth, Kevin N.</au><au>Navi, Babak B.</au><au>Kamel, Hooman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of Arterial Ischemic Events After Intracerebral Hemorrhage</atitle><jtitle>Stroke (1970)</jtitle><addtitle>Stroke</addtitle><date>2020-01</date><risdate>2020</risdate><volume>51</volume><issue>1</issue><spage>137</spage><epage>142</epage><pages>137-142</pages><issn>0039-2499</issn><eissn>1524-4628</eissn><abstract>BACKGROUND AND PURPOSE—The risk of arterial ischemic events after intracerebral hemorrhage (ICH) is poorly understood given the lack of a control group in prior studies. This study aimed to evaluate the risk of acute ischemic stroke and myocardial infarction (MI) among patients with and without ICH. METHODS—We performed a retrospective cohort study using claims data from Medicare beneficiaries from 2008 to 2014. Our exposure was acute ICH, identified using validated International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Our primary outcome was a composite of acute ischemic stroke and MI, whereas secondary outcomes were ischemic stroke alone and MI alone. We used Cox regression analysis to compute hazard ratios during 1-month intervals after ICH. Sensitivity analyses entailed exclusion of patients with atrial fibrillation and valvular heart disease. RESULTS—Among 1 760 439 Medicare beneficiaries, 5924 had ICH. The 1-year cumulative incidence of an arterial ischemic event was 5.7% (95% CI, 4.8–6.8) in patients with ICH and 1.8% (95% CI, 1.7–1.9) in patients without ICH. After adjusting for potential confounders, the risk of an arterial ischemic event remained significantly increased for the first 6 months after ICH and was especially high in the first month (hazard ratio, 6.7 [95% CI, 5.0–8.6]). In secondary analysis, the risk of ischemic stroke was increased in the first 6 months after ICH (hazard ratio, 6.1 [95% CI, 3.5–9.3]) but the risk of MI was not (hazard ratio, 1.6 [95% CI, 0.3–2.9]). In sensitivity analyses excluding patients with atrial fibrillation and valvular heart disease, the association between ICH and arterial ischemic events was similar to that of the primary analysis. CONCLUSIONS—In a large population-based cohort, we found that elderly patients with ICH had a substantially increased risk of ischemic stroke in the first 6 months after diagnosis. Further exploration of this risk is needed to determine optimal secondary prevention strategies for these patients.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>31771458</pmid><doi>10.1161/STROKEAHA.119.026207</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0039-2499
ispartof Stroke (1970), 2020-01, Vol.51 (1), p.137-142
issn 0039-2499
1524-4628
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7001742
source MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aged
Aged, 80 and over
Anticoagulants - therapeutic use
Atrial Fibrillation - complications
Atrial Fibrillation - epidemiology
Brain Ischemia - drug therapy
Brain Ischemia - epidemiology
Cerebral Hemorrhage - drug therapy
Cerebral Hemorrhage - epidemiology
Female
Humans
Male
Myocardial Infarction - drug therapy
Myocardial Infarction - epidemiology
Stroke - drug therapy
Stroke - epidemiology
United States
Warfarin - therapeutic use
title Risk of Arterial Ischemic Events After Intracerebral Hemorrhage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A54%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20Arterial%20Ischemic%20Events%20After%20Intracerebral%20Hemorrhage&rft.jtitle=Stroke%20(1970)&rft.au=Murthy,%20Santosh%20B.&rft.date=2020-01&rft.volume=51&rft.issue=1&rft.spage=137&rft.epage=142&rft.pages=137-142&rft.issn=0039-2499&rft.eissn=1524-4628&rft_id=info:doi/10.1161/STROKEAHA.119.026207&rft_dat=%3Cproquest_pubme%3E2319195205%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2319195205&rft_id=info:pmid/31771458&rfr_iscdi=true